Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02982694 |
| Title | Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Vall d'Hebron Institute of Oncology |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NLD | ITA | ESP | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| KU Leuven | Leuven | Belgium | Details | |||
| Ospedale Niguarda CA Granda | Milano | Italy | Details | |||
| Second University of Naples | Naples | Italy | Details | |||
| The Netherlands Cancer Institute | Amsterdam | Netherlands | Details | |||
| Institut Català d'Oncologia | Barcelona | Spain | Details | |||
| Vall d'Hebron Institute of Oncology | Barcelona | Spain | Details | |||
| Fundación Investigación Clínico de Valencia | Valencia | Spain | Details |